Form 4: Colgate-Palmolive Director Hundmejean Martina Reports Stock Option Exercise and Sale

Sentiment:

SEC Form 4 Filing


Director Hundmejean Martina reports exercising stock options and selling shares of Colgate-Palmolive common stock on August 23, 2024.

Summary

  • On August 23, 2024, Hundmejean Martina, a director of Colgate-Palmolive, exercised stock options to acquire 3,462 shares of common stock at a price of $69.38 per share.
  • Simultaneously, Ms. Hundmejean sold 2,313 shares of common stock at $103.86 per share.
  • Following these transactions, Ms. Hundmejean directly owns 11,755 shares of Colgate-Palmolive common stock.
  • The stock options were awarded under the issuer's incentive compensation plan and became exercisable in one-third increments beginning on the first anniversary of the May 11, 2020 grant date.

Sentiment

Score: 5

Explanation: Neutral sentiment as it is a standard disclosure of insider transactions.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to monitor potential insider sentiment and activity.

Stakeholder Impact

  • The transactions may provide insights to shareholders regarding management's view of the company's stock value.

Key Dates

DateDescription
05/11/2020Grant date of the stock options, which became exercisable in one-third increments beginning on the first anniversary of this date.
08/23/2024Date of stock option exercise and share sale.
08/27/2024Date of the Form 4 filing.
05/11/2028Expiration date of the stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.